R.H. Bluestein & Co’s GSK GSK Stock Holding History

R.H. Bluestein & Co’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	$353K	Buy	+12,000	New	+$353K	0.02%	202
2022 Q2	–	Sell	-14,400	Closed	-$784K	–	378
2022 Q1	$784K	Sell	14,400 -80	-0.6%	-$4.36K	0.03%	128
2021 Q4	$798K	Sell	14,480 -1,600	-10%	-$88.2K	0.03%	135
2021 Q3	$768K	Buy	16,080 +4,000	+33%	+$191K	0.03%	149
2021 Q2	$601K	Sell	12,080 -80	-0.7%	-$3.98K	0.02%	199
2021 Q1	$542K	Hold	12,160	–	–	0.02%	200
2020 Q4	$559K	Sell	12,160 -1,520	-11%	-$69.9K	0.02%	177
2020 Q3	$644K	Hold	13,680	–	–	0.03%	133
2020 Q2	$698K	Buy	13,680 +80	+0.6%	+$4.08K	0.04%	117
2020 Q1	$644K	Buy	13,600 +1,600	+13%	+$75.8K	0.05%	99
2019 Q4	$705K	Hold	12,000	–	–	0.04%	120
2019 Q3	$640K	Hold	12,000	–	–	0.04%	118
2019 Q2	$600K	Hold	12,000	–	–	0.03%	127
2019 Q1	$627K	Hold	12,000	–	–	0.03%	102
2018 Q4	$573K	Hold	12,000	–	–	0.04%	94
2018 Q3	$603K	Hold	12,000	–	–	0.03%	139
2018 Q2	$605K	Hold	12,000	–	–	0.03%	125
2018 Q1	$586K	Hold	12,000	–	–	0.03%	136
2017 Q4	$532K	Sell	12,000 -8,000	-40%	-$355K	0.03%	141
2017 Q3	$1.02M	Hold	20,000	–	–	0.06%	86
2017 Q2	$1.08M	Sell	20,000 -131	-0.7%	-$7.06K	0.06%	72
2017 Q1	$1.06M	Hold	20,131	–	–	0.06%	73
2016 Q4	$969K	Hold	20,131	–	–	0.06%	71
2016 Q3	$1.09M	Hold	20,131	–	–	0.07%	57
2016 Q2	$1.09M	Hold	20,131	–	–	0.08%	49
2016 Q1	$1.02M	Buy	20,131 +131	+0.7%	+$6.64K	0.07%	70
2015 Q4	$1.01M	Hold	20,000	–	–	0.06%	79
2015 Q3	$961K	Buy	20,000 +4,000	+25%	+$192K	0.07%	81
2015 Q2	$833K	Buy	16,000 +4,000	+33%	+$208K	0.05%	109
2015 Q1	$692K	Hold	12,000	–	–	0.04%	120
2014 Q4	$641K	Sell	12,000 -3,620	-23%	-$193K	0.04%	147
2014 Q3	$898K	Sell	15,620 -4,000	-20%	-$230K	0.06%	116
2014 Q2	$1.31M	Sell	19,620 -3,600	-16%	-$241K	0.08%	89
2014 Q1	$1.55M	Buy	23,220 +4,780	+26%	+$319K	0.1%	71
2013 Q4	$1.23M	Sell	18,440 -2,080	-10%	-$139K	0.08%	90
2013 Q3	$1.29M	Sell	20,520 -1,500	-7%	-$94.1K	0.09%	88
2013 Q2	$1.38M	Buy	+22,020	New	+$1.38M	0.12%	74